120 related articles for article (PubMed ID: 37888749)
1. Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability.
M M; Chhatar S; Gadre S; Paul S; Vaidya SP; Khatri S; Duari P; Kode J; Ingle A; Kolthur-Seetharam U; Patra M
Chemistry; 2024 Jan; 30(4):e202302720. PubMed ID: 37888749
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
4. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
6. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
7. New anticancer Pd and Pt complexes of tertamyl dithiocarbamate and DACH ligands against HT29 and Panc1 cell lines.
Hosseinzadeh S; Eslami Moghadam M; Sheshmani S; Shahvelayati AS
J Biomol Struct Dyn; 2022 Sep; 40(15):6910-6920. PubMed ID: 33645454
[TBL] [Abstract][Full Text] [Related]
8. Improve the anticancer potency of the platinum(II) complexes through functionalized leaving group.
Zhao J; Wang D; Xu G; Gou S
J Inorg Biochem; 2017 Oct; 175():20-28. PubMed ID: 28689065
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
11. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.
Arsenijevic M; Milovanovic M; Jovanovic S; Arsenijevic N; Markovic BS; Gazdic M; Volarevic V
J Biol Inorg Chem; 2017 Aug; 22(6):807-817. PubMed ID: 28421385
[TBL] [Abstract][Full Text] [Related]
13. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
Mauldin SK; Husain I; Sancar A; Chaney SG
Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamine.
Yamada H; Kato T; Hirose J; Inagaki K; Noji M; Kidani Y
Biochim Biophys Acta; 1990 Jul; 1049(3):298-302. PubMed ID: 2383586
[TBL] [Abstract][Full Text] [Related]
16. In-vitro cytotoxicity and in-vivo antitumor activity of two platinum complexes with 1,3-dimethyl pentyl glycine ligand against breast cancer.
Bazsefidpar P; Eftekhar E; Jahromi MZ; Nikpoor AR; Moghadam ME; Zolghadri S
J Inorg Biochem; 2023 Apr; 241():112144. PubMed ID: 36706492
[TBL] [Abstract][Full Text] [Related]
17. pH and thermo dual stimulus-responsive liposome nanoparticles for targeted delivery of platinum-acridine hybrid agent.
Zhou Q; You C; Ling Y; Wu H; Sun B
Life Sci; 2019 Jan; 217():41-48. PubMed ID: 30476500
[TBL] [Abstract][Full Text] [Related]
18. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
20. Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.
Siddik ZH; al-Baker S; Burditt TL; Khokhar AR
J Cancer Res Clin Oncol; 1993; 120(1-2):12-6. PubMed ID: 8270602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
